Daily news email for March 20, 2018 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
BioOutsource Ltd. Acquired by Sartorius Stedim Biotech

Sartorius Stedim Biotech Acquires UK-Based CRO, BioOutsource

Selvita to Release the Most Recent Results from Its Oncology Programs at the AACR Annual ...

Isarna Initiates First-in-Human Phase I Trial for ISTH0036 to Treat Advanced Glaucoma

Positive Clinical Study Results for Cellmid's Hair Growth Product Using Novel FGF5 Inhibitor

Scientists Test Deep Brain Stimulation As Potential Anorexia Therapy, University of Toronto Study Reveals

This Bay Area Anti-Aging Drug Company Is Secretly Preparing For s New FDA

AI Predicts Autism By Comparing Babies' Brains, University of North Carolina Study

Scaffolds Covered In Stem Cells And Silver Ions To Prevent Osteomyelitis, University of Missouri Reveals

Veracyte: An Ideal Medium-Term Runner With Long-Term Upside

BioSpace - Breaking News
Enanta Pharmaceuticals, Inc. Announces Grants Positive Opinion For An Eight-Week Treatment Option With AbbVie's VIEKIRAX(Ombitasvir/Paritaprevir/Ritonavir Tablets) + EXVIERA (Dasabuvir Tablets) For Patients With Genotype 1b Chronic Hepatitis C

Sunovion Announces Positive Topline Results From Study Evaluating Latuda (Lurasidone HCL) In Children And Adolescents With Bipolar Depression

La Jolla Pharma Announces Positive Top-Line Results From ATHOS-3 Phase 3 Study Of LJPC-501

Meet the Woman Developing the Next Generation of Insulin at Novo Nordisk A/S

Seattle's CTI BioPharma Names a New CEO

Biotech News - Business Wire
TheraVida Announces Publication of Phase 2 Results for THVD-102 in Hyperhidrosis

Arrakis Therapeutics Announces $38 Million Series A Financing to Target RNA with Small-Molecule Medicines and Names Michael Gilman Chairman and CEO

Glaukos Announces Participation in 29th Annual ROTH Conference

Exelixis Announces Clinical Trial Collaboration with Roche to Evaluate Cabozantinib and Atezolizumab in Locally Advanced or Metastatic Solid Tumors

Inotek Pharmaceuticals Announces Participation at Upcoming Investor Conferences

Biotech News - PR Newswire
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017

Natural Trends, Anti-pollution Protection Claims, and New Technologies are the Cornerstones of the Specialty Actives Market's Strong Growth, Finds Kline

DURECT Corporation Invites You to Join its Fourth Quarter 2016 Earnings Conference Call

Zimmer Biomet Holdings to Present at the Cowen and Company 37th Annual Health Care Conference

BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial Success

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Pfizer Ups Offer for AstraZeneca to $119B

FDA Rejects Novartis Serelaxin for Acute Heart Failure

Abbott Buys Chile's CFR Pharmaceuticals for $2.9B

Shedding Non-Core Assets

Expanding the Building Blocks of DNA

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
STENTYS Self-Apposing® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack Trials

Enzo Biochem Schedules Teleconference to Discuss Second Quarter Results on March 13, 2013 at 8:30 AM E.T.

Research and Markets: Thromboembolism Global Clinical Trials Review, H1, 2013

RegeneRx Receives Notice of Allowance for 2nd U.S. Heart Patent

Trevena to present results of TRV027 Phase 2a Study in Patients with Advanced Heart Failure

Clinical Trials - PR Newswire
Aaron Ciechanover, Israel Cancer Research Fund "Research Professor" Announces Breakthrough in Cancer Research

PRN's Omega-3 Hits Major Endpoints Against Placebo in a Study of Dry Eye Symptoms

MabVax Therapeutics Analyst Brief by ARCE Research: Creating the Techniques to Fight Cancer in the Future Issued by BrokerBank Securities, Inc.

Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology

Restoring Cellular Energy Signals May Offer Promise of Treating Mitochondrial Diseases in Humans

CNN Top Stories
Scarlett O'Hara's dress sells for $137,000

Your medical marijuana questions answered

Lawyer releases reserve deputy's training records

2.25 tons of cocaine seized

92,000 Mini Coopers recalled

Contract Pharma
Recipharm Completes Kemwell Acquisition

Sartorius Partners With EMBL

Selexis Inks Agreement With Sanofi

FDA Selects ICON to Validate PROs

TruTag, Spinnaker in Drug Delivery Partnership

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA refuerza las advertencias y cambia las instrucciones de prescripción para reducir el riesgo de sufrir reacciones alérgicas graves con el medicamento para la anemia Feraheme (ferumoxitol)

CDER Key Officials List

FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol)

Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA advierte de una reducción grave de la frecuencia cardiaca cuando se usa el medicamento antiarrítmico amiodarona junto con tratamientos contra la hepatitis C que contienen sofosbuvir (Harvoni o Sovaldi), en combinación con otro fármaco antivírico de acción directa

FDA Drug Safety Communication: FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir (Harvoni or Sovaldi) in combination with another Direct Acting Antiviral drug

FDA News - Business Wire
Acorda to Present at the Cowen and Company 37th Annual Healthcare Conference

BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

CureDuchenne Ventures Invests in New Gene Editing Company Exonics Therapeutics to Advance CRISPR/Cas9 Therapy for Duchenne Muscular Dystrophy

Bristol-Myers Squibb to Take Part in Cowen and Company 37th Annual Global Health Care Conference

AV Medical's Chameleon Receives Expanded Indication to Include Infusion of Diagnostic or Therapeutic Fluids

FDA Press Releases
FDA approves first-of-its-kind corneal implant to improve near vision in certain patients

FDA approves first generic Copaxone to treat multiple sclerosis

U.S. Marshals seize unapproved drugs from Florida distributor

FDA approves Corlanor to treat heart failure

FDA warns consumers not to use muscle growth product called Tri-Methyl Xtreme

FDA Vaccines, Blood and Biologics - What's New
Summary Basis for Regulatory Action, June 2, 2014 - Ruconest

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine

Draft Guidance for Industry: Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products

Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2014

Guidance for Industry: BLA for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System

FierceBiotech Radio on pharma's day on the Hill, biotech's paucity of M&A, and the gathering storm of biosimilars

Pursuing new deals to grow the pipeline, Szela axes staffers in Aegerion reorg

4D pharma buys Tucana to add diagnostic capabilities to microbiome R&D toolkit

AveXis and Proteostasis survive the market storm, IPOs raise $145M for R&D

Intercept books a date with the FDA as buyout rumors simmer

FierceBiotech IT
DNAnexus connects genomics platform to Sapio Sciences' LIMS

BioClinica rolls out tech-enabled postapproval research service

CosmosID raises $6M to advance microbiome bioinformatics offering

Illumina signs biobank deals to fuse genome data, EMRs

Stallergenes resumes work after IT-related shutdown, hires head of tech ops

FierceBiotech Research
Investigators at The Hutch draw up a new battle plan for metastasis

U.K. scientists get a green light to modify human embryos

Gene therapy pioneer James Wilson uses CRISPR/Cas9 to target liver disease

Researchers discover fusion protein that promotes cancer via three distinct ways in pediatric brain tumors

Oxford team fingers an inflammatory protein as a trigger for cancer

Pfizer builds on early Ibrance lead as Novartis, Lilly rivals inch closer

Some top GSK investors aren't sold on a breakup--and they're backing CEO Witty, too

After a big 2015, Regeneron predicts slowing 2016 sales for launch superstar Eylea

Top Senate Democrat grills HHS about opioid panel's alleged ties to industry

Sanofi's outlook less than sunny as key diabetes franchise continues to sag

FiercePharma Manufacturing
FDA quality focus will definitely mean winners and losers, report says

FDA warning to Ipca Labs shines light on rampant data falsification

Report says CMOs without U.S. facilities risk being left out of 'hot' market

Dr. Reddy's grows U.S. sales even in face of FDA action

Regulator suspends Spanish drugmaker over 'critical quality defects'

Merck, J&J, Pfizer consider joining Zika vaccine race

Pfizer's vaccine sales leap in 2015 thanks to Prevnar 13

Affinivax nets another $2.5M from Gates Foundation to advance Prevnar competitor

UT Southwestern team creates new drug that could aid in vaccine development

NCI's Cancer Centers join in HPV vaccination push

Health News - BizJournals.com
Humana CEO Broussard, other industry execs to meet with Trump today

How the state's newest Duchenne biotechs are getting a boost from patient groups

Biogen alums team up to launch Waltham biotech, with backing from Henri Termeer

Delaware biopharm company moves to S&P 500, inks alliance with Penn

'Growth mode' sandbags Mayo Clinic profits

Health News - CNBC
Germany's Merck Serono to produce medicines in UAE

Germany's Merck Serono to produce medicines in UAE

Analysis: Drugmakers step up search for hearing loss medicines

Grand jury probing meningitis-linked pharmacy: newspaper

Small Employers Weigh Impact of Providing Health Insurance

Health News - Fox Business
Trump to Lay Out Healthcare Revamp Details in Speech to Congress

BMW recalling 91,800 Mini Coopers to repair defect affecting front passenger air bag

Recalls this week include blowers, mowers, bike hooks, mattresses, toys, utility vehicles

Pharmaceuticals companies shares mixed at the close of trading

Managed Care companies shares down at the close of trading

Inside Industry - Gen
McKesson's $8.3B Celesio Deal Builds Drug Warehousing Powerhouse

DSM, Sanquin Make Factor IX-Recovering mAb Manufacturing Deal

Startup Wins Five-Year Exclusive License to deCODE Genetics Platform

Cleveland BioLabs Subsidiary Awarded $4.6M Russian Contract

Imugene Acquiring Biolife, as Lead Pipeline Candidate Nears Phase II

Marketwire - Pharma and Biotech
ORYZON Reports Financial Results and Corporate Update for the Fourth Quarter and Year Ended December 31, 2016

Dr. Timothy Greco Now Offers Volbella(R) in Philadelphia

RepliCel Life Sciences Announces Closing of Brokered and Non-brokered Private Placement

Elsevier Updates Infectious Diseases Reference Aimed at Controlling and Preventing Neglected and Emerging Worldwide Diseases

Diet Doc Offers Weight Loss And Weight Maintenance Alternatives To The Dangerous Original hCG Diet

MassBio News
MassBio Welcomes Seven New Board Members

MassBio to Host Art in Giving: Exhibit XX

Patient Profile: Promise for a Better Future

Patients are Rare Alone, Strong Together

The MassBio Employee Perks Program is Expanding

Medical Pharma - PR Newswire
John Theurer Cancer Center's Dr. Andre Goy Co-Chairs 21st Annual International Congress on Hematologic Malignancies

Flexpoint Ford Partners with SouthEast Eye Specialists and Center for Facial Rejuvenation

New Cancer Therapeutics Drive the Cancer Biological Therapy Market

NoNO Inc Initiates Phase III Study of NA-1 for Acute Ischemic Stroke

Medical Device Analytical Testing Outsourcing Market to Reach $8.3 Billion by 2025 - Outsourcing to Minimize Business Risks, Hasten Product Market Entry & Reduce Costs - Research and Markets

National Center for Biotechnology Information
MedGen News

NCBI Announcements


NLM Catalog New and Noteworthy

PubMed Central News

Nature Biotechnology
Research Highlights

Stretching sensors by confinement

Core promoters across the genome

Exploring protein sequencefunction landscapes

Industrializing rare disease therapy discovery and development

New York Times- Biotechnology
Seeking Support, Biotech Food Companies Pledge Transparency

A High-Tech Menagerie

Cornell Scientist’s Quest: Perfect Broccoli

After Patent Ruling, Availability of Gene Tests Could Broaden

Connecticut Approves Labeling Genetically Modified Foods

New York Times- Pharmaceuticals
A Dry Pipeline for Psychiatric Drugs

Death Row Improvises, Lacking Lethal Mix

A Musical Switch From Self-Pity to Gratitude

Warning: This Pill May Be Dangerous to Your Health

To Judge Sleep Aids, U.S. Looks at Drowsy Driving in the Morning

Help Wanted | Departmental EIR at a University Near You!

License Agreement: Clovis Oncology $CLVS (Celgene, $CELG)

License Agreement: Clovis Oncology $CLVS (Ethical Oncology Science, S.p.A, Servier, SA, and Advenchen Laboratories, LLC)

License Agreement: Clovis Onclology $CLVS (Pfizer, $PFE)

Summary: Array BioPharma $ARRY

Pall: Bioprocessing's future is made of virtual reality

EATRIS: Pharma has a vital role in translational medicine

Happy Holidays 2014 from William Reed Business Media!

A bitter pill to swallow: young people dislike tablets more than old

Consolidation prevalent in industry, says third largest CMO

Pharma News - Business Wire
Aimmune Therapeutics to Present AR101 Clinical Data in Peanut Allergy at the 2017 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

Digestive Enzyme Supplements Market to Reach $1.6 Billion by 2025 - Increasing Incidence of Gastrointestinal Tract Diseases - Research and Markets

Syros Reports Discovery of Novel Genomics Based Approach to Stratifying Patients with Acute Myeloid Leukemia at Cold Spring Harbor Conference

Walgreens Boots Alliance Publishes Corporate Social Responsibility Report 2016

Global Viral Partnering 2010-2017: Deal Trends, Players and Financials - Research and Markets

Pharma News - PharmiWeb
Ignyta Announces Multiple Presentations at the 2015 AACR Annual Meeting

Meeting the Needs of Ophthalmologists: ZEISS Showcases Integrated Solutions that Deliver Faster Practice and Surgical Workflow and Address Critical Diagnostic Challenges

SanBio Presents at Annual European Stroke Organisation Conference

A Cure for Global Warming plus Drought Relief

MEDIA ADVISORY: Assemblymember Linda B. Rosenthal AARP Team up to Announce Major Step for 4M Family Caregivers

Pharma News - PR Newswire
$8.8 Billion Cardiac Resynchronization Therapy (CRT) Market - Analysis By Product (Cardiac Resynchronization Therapy Pacemakers [CRT-P], Cardiac Resynchronization Therapy Defibrillators [CRT-D]) - Research and Markets

Technical Reports on Generic Drugs Stocks -- Zoetis, Mallinckrodt, Akorn, and MYOS RENS Technology

Landmark Study: Meta-Analysis of 28 Studies Shows Stretta Therapy for GERD Consistently and Significantly Improves Outcomes

Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® PUDDING (barium sulfate) oral paste for Fluoroscopy

Allergan's New Eyepowerment Campaign Urges The Up To 33 Million Americans Suffering from Symptoms of Chronic Dry Eye to Take Action

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
San Antonio, TX Author Publishes Ode to Pet Dog

CD Genomics Introduced the Newest HiSeq X Ten System for Its Human Whole Genome Sequencing Service

Key Virulence Factors of Parkinson's Disease by Creative Animodel

Kingdom BioFuel Offers Free Lifetime Delivery of Wood Pellets in PA and Free Ton of Pellets with Purchase of a Pellet Stove

Winter Springs, FL Author Publishes Spiritual Book of Poetry

PRWeb - Biotechnology
Reed Tech Announces FDA Lot Distribution Report (LDR) Service for...

Hemodynamic Monitoring Systems Market to Reach $1,107.4 Million by...

MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life...

Providence Fertility Center Physicians Will Be Featured on WPRI 12's...

Software Defined Data Center Market Reaches $77.18 Billion by 2020...

PRWeb - Pharmaceuticals
DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management...

Testosterone Treatment Lawsuits Increase, as New Report Indicates Over...

Global Hepatitis (A, B) Vaccine Market Analysis Report 2015-2020

First ConCert by HIMSS certified Ambulatory EHR and Patient...

Reducing Drug and Device Batch Release Times: Expert Reveals Secrets...

Scientific American
Volcanic Eruption May Have Plunged the Maya into a "Dark Age"

What Makes for the Hottest Dance Moves Hips Don't Lie [Video]

Maternal Health Care Is Disappearing in Rural America

Can Artificial Intelligence Predict Earthquakes

Nerve Cells That Go Out on a Limb Show How the Ability to Tweet Evolved

Sports - ESPN Basketball
UConn lands instantly eligible transfer Miller

Purdue C Hammons will return for final season

Fighting Illini add Charlotte transfer Thorne

Open-heart surgery successful for ISU's Hoiberg

K-State freshman Harris dismissed from program

Sports News - ESPN
Ohio St. draws 99,391 to set spring game record

Attorney: New NCAA head-injury deal just as bad

Time for Utah's Hunter Dimick to make superhero transition

UNC's defense won't be an easy fix

Jake Brendel keeps UCLA's line moving

Xconomy Life Sciences
After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future

Cashing in On Duchenne Approval, Sarepta Sells Voucher to Gilead For $125M

Argos Shares Crater on Futility Finding for Kidney Cancer Therapy

Genomenon's Software Seeks to Give Geneticists Faster Insights

Cidara Antifungal Flunks in Phase 2 Clinical Trial, Sinking Shares

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)